Compositions and methods for the use of Bcl-2 transfected neurons
OwnerKenneth Haglid, Shu Wanginventors
Life of this patent
Estimating the term…
Abstract
The use of Bcl-2 transfected neurons and/or stem cells for the production of a pharmaceutical preparation for in vivo treatment of neurological conditions such as Parkinson's disease is disclosed. Also disclosed is a method for treatment of neurological conditions, wherein Bcl-2 transfected neurons are transplanted to a patient.
Claims26
A composition for the in vivo treatment of neurological conditions in mammals comprising Bcl-2-transfected neurons.
A method for the in vivo treatment of neurological conditions in mammals comprising administering Bcl-2-transfected neurons to a mammal in need of said treatment.
A composition for the in vivo treatment of a neurological condition comprising Bcl-2-transfected neurons, wherein said neurons produce dopamine upon transplantation into a mammal.
A method of treating Parkinson's disease in mammals comprising administering Bcl-2 transfected neurons to a mammal in need of such treatment.
Dependencies are inferred from the claim text.